Results 301 to 310 of about 103,807 (331)
Some of the next articles are maybe not open access.
[18F]Fluorodeoxyglucose PET in Thoracic Malignancies
PET Clinics, 2014[(18)F]Fluorodeoxyglucose (FDG) PET is a robust quantitative molecular imaging technique that complements available structural imaging techniques for the detection and characterization of malignancy. This article provides an overview of the utility and applications of FDG-PET for the evaluation of patients with thoracic malignancy.
Vilstrup, Mie Holm, Torigian, Drew
openaire +2 more sources
Fluorodeoxyglucose-PET in the management of breast cancer
Radiologic Clinics of North America, 2004FDG-PET can be helpful in the diagnosis of primary breast cancer, especially in patients with dense breast tissue, significant fibrocystic changes, fibrosis after radiotherapy, and inconclusive results from MR imaging and other imaging modalities. PET has a limited role in patients with very small tumors and with well-differentiated and lobular types ...
Rakesh, Kumar, Abass, Alavi
openaire +2 more sources
Muscle uptake of 18-fluorine fluorodeoxyglucose
Seminars in Nuclear Medicine, 2000F LUORODEOXYGLUCOSE (FDG) is well established as a tumor-seeking agent that is taken up by a wide variety of malignant tumors. Several nonmalignant lesions also are FDG avid, as are normal organ systems that use glucose as part of their metabolism. Low-grade FDG uptake in muscles is part of the normal biodistribution pattern of FDG, especially during ...
Robert C. Stadalnik, Rachel Bar-Shalom
openaire +2 more sources
The Unique Role of Fluorodeoxyglucose-PET in Radioembolization
PET Clinics, 2019Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry.
Bastiaannet, Remco +3 more
openaire +3 more sources
Brain fluorodeoxyglucose (FDG) PET in dementia
Ageing Research Reviews, 2016The purpose of this article is to present a selective and concise summary of fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG PET is used to visualize a downstream topographical marker that indicates the distribution of neural injury or synaptic dysfunction, and can identify distinct phenotypes of dementia due to ...
Takashi, Kato +3 more
openaire +2 more sources
Fluorodeoxyglucose-PET in the management of malignant melanoma
Radiologic Clinics of North America, 2005FDG-PET is of limited use in patients with early-stage disease without nodal or distant metastases (stage I-II), because sentinel node biopsy is much more sensitive in detecting microscopic lymph node metastases. Because of the high tumor-to-background ratio, FDG-PET can highlight metastases at unusual sites that are easily missed with conventional ...
Rakesh, Kumar +3 more
openaire +2 more sources
PET Clinics, 2022
Molecular imaging with PET-computerized tomography (PET-CT) plays an important role in oncology. There is current and evolving evidence supporting the use of fluorodeoxyglucose (FDG) and non-FDG tracers in assessment patients with hepatobiliary and pancreatic cancers in various clinical scenarios.
Gopinath, Gnanasegaran +2 more
openaire +2 more sources
Molecular imaging with PET-computerized tomography (PET-CT) plays an important role in oncology. There is current and evolving evidence supporting the use of fluorodeoxyglucose (FDG) and non-FDG tracers in assessment patients with hepatobiliary and pancreatic cancers in various clinical scenarios.
Gopinath, Gnanasegaran +2 more
openaire +2 more sources
Fluorodeoxyglucose-avid thyroid incidentaloma
Thyroid Research and Practice, 2020Positron emission tomography–computed tomography (PET-CT) has become a standard investigation oncology workup.18F-fluorodeoxyglucose (18F-FDG) is the main radiopharmaceuticals for most of the studies. Since malignant cells overexpress glucose transporter receptors, they internalize FDG, and FDG undergoes the first rate-limiting step of glycolysis to ...
Sujoy Ghosh, Deepanjan Mitra
openaire +1 more source
PET clinics, 2022
PET/computed tomography (CT) with fluorodeoxyglucose and nonfluorodeoxyglucose PET tracers has established itself in the management of malignant disorders. Its role in the assessment of nonmalignant conditions, such as infectious and noninfectious inflammatory diseases and other benign conditions, has emerged independently and alongside its role being ...
Vandana Kumar, Dhingra +3 more
openaire +1 more source
PET/computed tomography (CT) with fluorodeoxyglucose and nonfluorodeoxyglucose PET tracers has established itself in the management of malignant disorders. Its role in the assessment of nonmalignant conditions, such as infectious and noninfectious inflammatory diseases and other benign conditions, has emerged independently and alongside its role being ...
Vandana Kumar, Dhingra +3 more
openaire +1 more source
Fluorodeoxyglucose PET in Relapsing Polychondritis
New England Journal of Medicine, 2008The authors report on a case of fever of unknown origin in which 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) was instrumental in depicting cartilage inflammation, which eventual...
Frank De Geeter +1 more
openaire +1 more source